Ivana Gojo - Concepedia

Author

Ivana Gojo

Sidney Kimmel Comprehensive Cancer Center ORCID

Also Known As

Frederic Galacteros, I Gojo, I. Gojo, Ivana Gojo, Li, Ling, Mathangi Gopalakrishnan

265

Publications

9.3K

Citations

H-Index

Concepts

All Affiliations

Sidney Kimmel Comprehensive Cancer Center University of Maryland, Baltimore Johns Hopkins University The University of Texas MD Anderson Cancer Center Moffitt Cancer Center

About

Ivana Gojo is an author at Sidney Kimmel Comprehensive Cancer Center specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	36	3.2K
2	Health Sciences	8	8	768
3	Natural Sciences	2	2	215
4	Education	1	1	38
5	Engineering	1	1	57

Ivana Gojo

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, Blood	2001	445
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation Cristina Toffalori, Laura Zito, Valentina Gambacorta, Nature Medicine Hematological MalignancyImmune SignatureTransplantationLeukemia EscapeMalignant Blood Disorder	2019	393
Myeloid cell factor–1 is a critical survival factor for multiple myeloma Bin Zhang, Ivana Gojo, Robert G. Fenton Blood	2002	366
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 Daniel A. Pollyea, Dale L. Bixby, Alexander E. Perl, Journal of the National Comprehensive Cancer Network Hematological MalignancyTranslational MedicineOncologyMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2021	314
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, Blood	2015	297
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias Ivana Gojo, Anchalee Jiemjit, Jane B. Trepel, Blood	2006	282
The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Ivana Gojo, Bin Zhang, Robert G. Fenton PubMed ApoptosisImmunologyCell DeathCancer BiologyTranscriptional Repression	2002	243
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince, Journal of Clinical Oncology	2015	237
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy Hanna A. Knaus, Sofia Berglund, Hubert Hackl, JCI Insight	2018	209
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS Christopher G. Kanakry, Hua-Ling Tsai, Javier Bolaños‐Meade, Blood	2014	196

Page 1